Systemic Autoimmune Disorder with Pulmonary Involvement: Novel Insights from Underlying Mechanisms of Drug Development and Intervention
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Respiratory Medicine".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 992
Special Issue Editor
Interests: COVID-19; interstitial lung diseases; metabolic dysfuntion in chronic respiratory disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Rheumatic diseases include a wide range of disorders with a notable impact on quality of life, as well as significant morbidity and mortality worldwide. Pulmonary involvement is overall frequent, representing a prognostic factor of negative outcomes in patients with connective tissue disorders. During the last few decades, several studies have addressed the immune-mediated mechanisms of lung involvement in patients with systemic autoimmune disorders (SARDs). However, several pathogenetic mechanisms are still far from being clarified, and there is a general lack of knowledge about the heterogeneity of lung involvement in patients with SARDs.
The clinical breakthrough of novel antifibrotic agents and their interconnection with different immunomodulatory agents have led to significant changes in the therapeutic scenario, boosting the development of pharmacological research for these patients.
In this Special Issue, we aim to include original research and review articles focused on early diagnosis, and innovative treatments for patients with pulmonary involvement of systemic autoimmune disorders.
Dr. Fabio Perrotta
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rheumatic diseases
- pulmonary involvement
- connective tissue disorders
- systemic autoimmune disorders (SARDs)
- diagnosis
- innovative treatments
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
